Page last updated: 2024-08-23

etoposide and Lymphoma, AIDS-Related

etoposide has been researched along with Lymphoma, AIDS-Related in 63 studies

Research

Studies (63)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's13 (20.63)18.2507
2000's34 (53.97)29.6817
2010's14 (22.22)24.3611
2020's2 (3.17)2.80

Authors

AuthorsStudies
Hagiwara, S; Nagai, H; Okada, S; Saito, AM; Uehira, T1
Aboulafia, D; Ambinder, RF; Baiocchi, R; Capoferri, AA; Cesarman, E; Chadburn, A; Durand, CM; Kaplan, L; Lee, JY; Mitsuyasu, R; Moore, PC; Noy, A; Ramos, JC; Ratner, L; Reid, EG; Rubinstein, PG; Siegel, ER; Sparano, JA1
Ambinder, RF; Hunter, NB; Vogt, S1
Aurer, I; Bašić-Kinda, S; Grah, JJ; Ilić, I; Radman, I1
Barta, SK; Boue, F; Dunleavy, K; Galicier, L; Garcia, O; Kaplan, LD; Lee, JY; Little, RF; Morgades, M; Mounier, N; Navarro, JT; Noy, A; Oriol, A; Ratner, L; Remick, SC; Ribera, JM; Sparano, JA; Spina, M; Tamari, R; Tirelli, U; Wang, D; Weiss, R; Wilson, WH; Wyen, C; Xue, X1
Levine, AM1
Ajisawa, A; Hagiwara, S; Kitanaka, A; Kojima, Y; Nagai, H; Okada, S; Tanuma, J; Uehira, T1
Hensel, M; Hentrich, M; Hoffmann, C; Mosthaf, F; Müller, M; Siehl, J; Wyen, C1
Amorosa, V; Frank, D; Harrison, N; Shah, NN; Stonecypher, M; Svoboda, J1
Ambinder, RF; Epeldegui, M; Lee, JY; Magpantay, LI; Martínez, AC; Martínez-Maza, O; Mitsuyasu, R; Regidor, D; Sparano, JA; Widney, DP1
Hagiwara, S; Kawabata, KC; Miwa, A; Oka, S; Tachikawa, N; Takenouchi, A; Tanimura, A; Tanuma, J1
Abdallah, FK; Ayers, LW; Bako, J; Banura, C; Black, J; Fu, P; Johnson, JL; Kakembo, J; Katongole-Mbidde, E; Lederman, MM; Meyerson, HJ; Mwanda, WO; Ness, A; Onyango, CA; Orem, J; Remick, SC; Reynolds, S; Subbiah, V; Wabinga, H; Whalen, CC1
Lerner, A; Rosen, JE; Soto, J1
Hayashi, H; Kakimoto, T; Kurai, H; Mihara, A; Nakazato, T; Sanada, Y; Suzuki, K; Tachikawa, N; Yoshida, S; Yoshimura, Y1
Bower, M; Gazzard, B; Lee, B; Merchant, S; Naresh, K; Nelson, M; Newsom-Davis, T; Stebbing, J1
Castillo, JJ; Echenique, IA1
Garcia, JA; Krantz, MJ; Kriekard, P; Nardi-Korver, L1
Alt, J; Arasteh, K; Berger, M; Engert, A; Fätkenheuer, G; Hentrich, M; Hoffmann, C; Mosthaf, F; Müller, M; Nickelsen, M; Planker, M; Rieke, A; Rockstroh, JK; Schmidmaier, R; Schürmann, D; Seidel, E; Siehl, J; Wolf, T; Wyen, C1
Ammassari, A; Antinori, A; di Gennaro, G; Fasan, M; Gabarre, J; Mena, M; Nigra, E; Rossi, G; Schiantarelli, C; Spina, M; Talamini, R; Tirelli, U; Vaccher, E1
Berkow, RL; Hilliard, LM; Watts, RG1
Boulanger, E; Brière, J; Droz, D; Gaulard, P; Oksenhendler, E1
Franchini, G; Grant, N; Gutierrez, M; Jaffe, ES; Kavlick, MF; Little, RF; Mitsuya, H; Pittaluga, S; Raffeld, M; Shearer, G; Steinberg, SM; Wilson, WH; Yarchoan, R1
Goy, A; Hedrick, E; Moskowitz, C; Noy, A; Portlock, C; Qin, J; Straus, DJ; Teruya-Feldstein, J; Wang, ES; Zelenetz, AD1
Aboulafia, DM; Waddington, TW1
Ambinder, RF; Chen, MG; Einzig, A; Henry, DH; Lee, S; Li, T; Manalo, J; Nazeer, T; Sparano, JA; Von Roenn, JH1
Bower, M; Davies, L; Gazzard, B; Gupta, S; McCall-Peat, N; Nelson, M; Ryan, N; Stebbing, J; Young, AM1
Berretta, M; Cattaneo, C; Jaeger, U; Michieli, M; Nigra, E; Rieger, AC; Rossi, G; Simonelli, C; Sparano, JA; Spina, M; Talamini, R; Tirelli, U; Vaccher, E1
Aboulafia, DM; Dezube, BJ; Pantanowitz, L1
Bower, M; Powles, T; Stebbing, J; Thirlwell, C1
Straus, DJ1
Abella, E; Brunet, S; del Potro, E; Esteve, J; Oriol, A; Ribera, JM1
Kaplan, LD1
Enschede, SH; Gregory, SA; Larson, ML1
Arts, K; Brandwein, J; Crump, M; Dotten, DA; Foote, M; Franssen, E; Routy, JP; Sawka, CA; Shepherd, FA; St-Louis, J; Taylor, M; Walker, IR1
Fu, P; Mwanda, WO; Ness, A; Orem, J; Remick, SC1
Aboulafia, DM; Combs, S; Neil, N1
Borie, R; Daniel, MT; Fieschi, C; Galicier, L; Gérard, L; Meignin, V; Oksenhendler, E1
Dham, SK; Gelfand, Y; Nagajothi, N; Sanmugarajah, J1
Apperley, J; Bower, M; Chaidos, A; Gabriel, I; Gazzard, B; Giles, C; Kanfer, E; Kew, A; Nelson, M1
Daguenel, A; Gorin, NC; Laporte, JP; Lesage, S; Najman, A; Parlier, Y; Woler, M1
Hahn, J; Herndier, B; Kaplan, LD; McGrath, MS; Meeker, TC; Ng, V; Shiramizu, B; Volberding, PA1
Cheson, BD; Feigal, EG1
Becker, NH; Carney, D; Elkind, R; Leaf, A; Sarta, C; Shah, M; Sparano, JA; Strack, M; Valentine, ES; Wiernik, PH1
Blanchard, CG; Eastman, AY; McSharry, JJ; Pearce, T; Portuese, E; Powell, D; Remick, SC; Wagner, H; Wighton, T; Wolf, BC1
Byrnes, JJ; Cabral, L; Fletcher, MA; Freidlander, A; Harrington, WJ; Patarca, R1
Dutcher, JP; Henry, DH; Hu, X; Mason, B; Ratech, H; Sarta, C; Schwartz, EL; Soeiro, R; Sparano, JA; Wiernik, PH1
Azar, N; Binet, JL; Boccaccio, C; Charlotte, F; Gabarre, J; Gentilini, M; Gonzalez, H; Jouan, M; Leblond, V; Sutton, L1
Hanau, L; Henry, DH; Hu, X; Reddy, DM; Sarta, C; Sparano, JA; Wiernik, PH1
Cheng, AL; Hung, RL; Liu, MY; Uen, WC; Wang, CH; Yeh, KH1
Cadeo, G; Carosi, G; Casari, S; Donisi, A; Re, A; Rossi, G; Stellini, R1
Henry, DH; Hu, X; Ratech, H; Sarta, C; Sparano, JA; Wiernik, PH1
Desai, J; Henry, DH; Llena, J; Mitnick, RJ; Sparano, JA1
Fasan, M; Gabarre, J; Spina, M; Tirelli, U; Vaccher, E1
Cazals-Hatem, D; Chevret, S; Clauvel, JP; Dubreuil, ML; Gerard, L; Levy, Y; Matheron, S; Oksenhendler, E1
Douglas, R; Michael, B; Nabil, S; Thomas, F1
Blanchard, CG; Dezube, BJ; Haase, RF; Mastrianni, DM; Nazeer, T; Ramnes, CR; Remick, SC; Sedransk, N1
Gutierrez, M; Horne, M; Jaffe, ES; Little, RF; Pau, A; Wilson, W1
Levine, AM; Seneviratne, L; Tulpule, A1
Antinori, A; Fasan, M; Juzbasic, S; Milan, I; Nasti, G; Nigra, E; Spina, M; Talamini, R; Tirelli, U; Vaccher, E1
Barber, GN; Boise, LH; Cabral, L; Deyev, VV; Harrington, WJ; Liu, LH; Podack, ER; Scott, D; Toomey, NL; Wood, C1
Bi, J; Boswell, W; Espina, BM; Levine, AM; Tulpule, A1
Benci, A; Blanc, PL; Jaeger, U; Liberati, AM; Nigra, E; Sparano, JA; Spina, M; Tirelli, U1
Agbalika, F; Boulanger, E; Daniel, MT; Grollet, L; Maarek, O; Molina, JM; Oksenhendler, E; Sigaux, F1

Reviews

7 review(s) available for etoposide and Lymphoma, AIDS-Related

ArticleYear
Treatment of HIV-Associated Lymphomas: The Latest Approaches for Optimizing Outcomes.
    Oncology (Williston Park, N.Y.), 2017, 12-15, Volume: 31, Issue:12

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, AIDS-Related; Lymphoma, Large B-Cell, Diffuse; Plasmablastic Lymphoma; Prednisone; Rituximab; Vincristine

2017
Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients.
    Blood, 2013, Nov-07, Volume: 122, Issue:19

    Topics: Anti-HIV Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; HIV; HIV Infections; Humans; Infusions, Intravenous; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Prednisone; Rituximab; Survival Analysis; Treatment Outcome; Vincristine

2013
Rituximab in combination with chemotherapy versus chemotherapy alone in HIV-associated non-Hodgkin lymphoma: a pooled analysis of 15 prospective studies.
    American journal of hematology, 2012, Volume: 87, Issue:3

    Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; HIV Infections; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Odds Ratio; Prednisone; Prospective Studies; Randomized Controlled Trials as Topic; Rituximab; Treatment Outcome; Vincristine

2012
AIDS-related non-Hodgkin lymphoma: still a problem in the era of HAART.
    The AIDS reader, 2004, Volume: 14, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Cyclophosphamide; Doxorubicin; Etoposide; Female; HIV Infections; Humans; Incidence; Lymphoma, AIDS-Related; Male; Middle Aged; Prednisone; Radiography; Registries; United States; Vincristine

2004
HIV-related lymphoma treated with maintenance thalidomide.
    Clinical advances in hematology & oncology : H&O, 2005, Volume: 3, Issue:3

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Axilla; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Immunotherapy; Lymphatic Irradiation; Lymphoma, AIDS-Related; Lymphoma, Large B-Cell, Diffuse; Male; Prednisone; Randomized Controlled Trials as Topic; Remission Induction; Rituximab; Thalidomide; Vincristine

2005
Incidence and management of AIDS-related lymphoma.
    Oncology (Williston Park, N.Y.), 2001, Volume: 15, Issue:5

    Topics: Antineoplastic Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Immunosuppressive Agents; Incidence; Lymphoma, AIDS-Related; Male; Risk Factors

2001
A clinical, molecular and cytogenetic study of 12 cases of human herpesvirus 8 associated primary effusion lymphoma in HIV-infected patients.
    The hematology journal : the official journal of the European Haematology Association, 2001, Volume: 2, Issue:3

    Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bleomycin; Chromosome Aberrations; Cidofovir; Cyclophosphamide; Cytosine; Doxorubicin; Drug Therapy, Combination; Etoposide; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Herpesviridae Infections; Herpesvirus 8, Human; Humans; Immunophenotyping; Interferon-alpha; Karyotyping; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Lymphoma, Large-Cell, Immunoblastic; Male; Methotrexate; Middle Aged; Organophosphonates; Organophosphorus Compounds; Polymerase Chain Reaction; Prednisone; Prognosis; Remission Induction; Survival Analysis; Vincristine; Vindesine; Viral Load

2001

Trials

19 trial(s) available for etoposide and Lymphoma, AIDS-Related

ArticleYear
Autologous peripheral blood stem cell transplantation for relapsed/refractory HIV-associated lymphoma: a phase II clinical study.
    International journal of hematology, 2020, Volume: 111, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Feasibility Studies; Humans; Lymphoma, AIDS-Related; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Peripheral Blood Stem Cell Transplantation; Safety; Survival Rate; Transplantation, Autologous

2020
Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial).
    Blood, 2020, 09-10, Volume: 136, Issue:11

    Topics: Adult; Aged; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; CD4 Lymphocyte Count; Cyclophosphamide; DNA, Viral; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Genes, myc; Herpesviridae Infections; Herpesvirus 4, Human; Herpesvirus 8, Human; Histone Deacetylase Inhibitors; HIV Infections; HIV-1; Humans; Kaplan-Meier Estimate; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Prednisone; Progression-Free Survival; Prospective Studies; Rituximab; Thrombocytopenia; Treatment Outcome; Vincristine; Viral Load; Vorinostat

2020
Predictive Value of Cytokines and Immune Activation Biomarkers in AIDS-Related Non-Hodgkin Lymphoma Treated with Rituximab plus Infusional EPOCH (AMC-034 trial).
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2016, Jan-15, Volume: 22, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Cytokines; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Lymphocyte Activation; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Prednisone; Rituximab; Vincristine

2016
Stage-adapted treatment of HIV-associated Hodgkin lymphoma: results of a prospective multicenter study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Nov-20, Volume: 30, Issue:33

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; HIV Infections; Hodgkin Disease; Humans; Lymphoma, AIDS-Related; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Prospective Studies; Remission Induction; Treatment Outcome; Vinblastine; Vincristine; Young Adult

2012
Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection.
    Blood, 2002, Sep-15, Volume: 100, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bleomycin; Disease-Free Survival; Doxorubicin; Etoposide; HIV Infections; HIV-1; Hodgkin Disease; Humans; Lymphoma, AIDS-Related; Male; Mechlorethamine; Middle Aged; Prednisone; Prognosis; Prospective Studies; Remission Induction; Survival Analysis; Survival Rate; Vinblastine; Vincristine

2002
Phase II trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Trial (E1494).
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Apr-15, Volume: 22, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, AIDS-Related; Middle Aged; Prognosis; Treatment Outcome

2004
Protease inhibitors potentiate chemotherapy-induced neutropenia.
    Blood, 2004, Nov-01, Volume: 104, Issue:9

    Topics: Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Cyclophosphamide; Doxorubicin; Drug Synergism; Etoposide; Female; Humans; Infections; Kinetics; Lymphoma, AIDS-Related; Male; Myeloablative Agonists; Neutropenia; Protease Inhibitors; Survival Analysis; Treatment Outcome

2004
Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials.
    Blood, 2005, Mar-01, Volume: 105, Issue:5

    Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Cyclophosphamide; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Infections; Infusions, Intravenous; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Male; Middle Aged; Opportunistic Infections; Remission Induction; Rituximab; Survival Analysis

2005
A prospective, non-randomised phase 1-2 trial of VACOP-B with filgrastim support for HIV-related non-Hodgkin's lymphoma.
    Biotechnology annual review, 2005, Volume: 11

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD4 Lymphocyte Count; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Injections, Intravenous; Injections, Subcutaneous; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prospective Studies; Recombinant Proteins; Survival Analysis; Treatment Outcome; Vincristine

2005
Oral combination chemotherapy in the treatment of AIDS-associated Hodgkin's disease.
    East African medical journal, 2005, Volume: 82, Issue:9 Suppl

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Cyclophosphamide; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Lymphoma, AIDS-Related; Male; Middle Aged; Procarbazine; Survival Analysis

2005
Intensive chemotherapy regimen (LMB86) for St Jude stage IV AIDS-related Burkitt lymphoma/leukemia: a prospective study.
    Blood, 2007, Oct-15, Volume: 110, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Burkitt Lymphoma; CD4 Lymphocyte Count; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, AIDS-Related; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Prospective Studies; Treatment Outcome; Vincristine

2007
Infusional cyclophosphamide, doxorubicin and etoposide in HIV-related non-Hodgkin's lymphoma: a follow-up report of a highly active regimen.
    Leukemia & lymphoma, 1994, Volume: 14, Issue:3-4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Lymphocyte Subsets; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pilot Projects; Quality of Life

1994
Peripheral blood T cell subsets as prognostic indicators of chemotherapy outcome in AIDS patients with large cell lymphoma.
    AIDS research and human retroviruses, 1996, May-20, Volume: 12, Issue:8

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bleomycin; CD4 Lymphocyte Count; Cyclophosphamide; Didanosine; Doxorubicin; Etoposide; Humans; Lymphoma, AIDS-Related; Lymphoma, Large B-Cell, Diffuse; Prednisone; Prognosis; Reverse Transcriptase Inhibitors; T-Lymphocyte Subsets; Treatment Outcome; Vincristine

1996
Effects of recombinant granulocyte colony-stimulating factor (G-CSF) in patients treated with ProMACE-CytaBOM for HIV-related non-Hodgkin's lymphoma (NHL).
    Haematologica, 1998, Volume: 83, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; HIV; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Recombinant Proteins; Retrospective Studies; Treatment Outcome; Vincristine

1998
Saquinavir enhances the mucosal toxicity of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma.
    Medical oncology (Northwood, London, England), 1998, Volume: 15, Issue:1

    Topics: Adult; Aged; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; CD4 Lymphocyte Count; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; HIV Protease Inhibitors; Humans; Logistic Models; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Saquinavir; Treatment Outcome

1998
Stanford V regimen and concomitant highly active antiretroviral therapy is feasible and active in patients with Hodgkin's disease and HIV infection.
    AIDS (London, England), 2000, Jul-07, Volume: 14, Issue:10

    Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Etoposide; Female; HIV; HIV Infections; Hodgkin Disease; Humans; Lymphoma, AIDS-Related; Male; Mechlorethamine; Middle Aged; Prednisone; Vinblastine; Vincristine

2000
Oral combination chemotherapy in conjunction with filgrastim (G-CSF) in the treatment of AIDS-related non-Hodgkin's lymphoma: evaluation of the role of G-CSF; quality-of-life analysis and long-term follow-up.
    American journal of hematology, 2001, Volume: 66, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Cyclophosphamide; Etoposide; Female; Filgrastim; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Lomustine; Lymphoma, AIDS-Related; Male; Middle Aged; Neoplasm Staging; Outcome Assessment, Health Care; Procarbazine; Prognosis; Quality of Life; Recombinant Proteins; Survival Rate; Treatment Outcome

2001
Human immunodeficiency virus-related non-Hodgkin lymphoma: activity of infusional cyclophosphamide, doxorubicin, and etoposide as second-line chemotherapy in 40 patients.
    Cancer, 2001, Jul-01, Volume: 92, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Infusions, Intravenous; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Treatment Outcome

2001
Infusional CDE with rituximab for the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: preliminary results of a phase I/II study.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 2002, Volume: 159

    Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Infusions, Intravenous; Lymphoma, AIDS-Related; Male; Middle Aged; Rituximab; Treatment Outcome

2002

Other Studies

37 other study(ies) available for etoposide and Lymphoma, AIDS-Related

ArticleYear
Burkitt lymphomas failing dose-adjusted R-EPOCH (DA-R-EPOCH).
    Annals of hematology, 2014, Volume: 93, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Lymphoma, AIDS-Related; Male; Multiple Organ Failure; Prednisone; Treatment Failure; Vincristine

2014
AIDS-lymphoma (ARL): one more step along the way.
    Blood, 2013, Nov-07, Volume: 122, Issue:19

    Topics: Anti-HIV Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; HIV Infections; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Prednisone; Rituximab; Vincristine

2013
Clinical outcomes of AIDS-related Burkitt lymphoma: a multi-institution retrospective survey in Japan.
    Japanese journal of clinical oncology, 2014, Volume: 44, Issue:4

    Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Induction Chemotherapy; Japan; Kaplan-Meier Estimate; Lymphoma, AIDS-Related; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Rituximab; Treatment Outcome; Vincristine

2014
Therapy of HIV-associated lymphoma-recommendations of the oncology working group of the German Study Group of Physicians in Private Practice Treating HIV-Infected Patients (DAGNÄ), in cooperation with the German AIDS Society (DAIG).
    Annals of hematology, 2014, Volume: 93, Issue:6

    Topics: Anti-HIV Agents; Antibiotic Prophylaxis; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Castleman Disease; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Interactions; Etoposide; Hematopoietic Stem Cell Transplantation; HIV Infections; Humans; Lymphoma, AIDS-Related; Methotrexate; Neoplasm Staging; Prednisolone; Prednisone; Radiotherapy, Adjuvant; Risk Assessment; Rituximab; Vincristine

2014
Extracavitary primary effusion lymphoma initially presenting with hemophagocytic lymphohistocytosis.
    Clinical lymphoma, myeloma & leukemia, 2014, Volume: 14, Issue:5

    Topics: Adrenal Cortex Hormones; Adult; Anti-HIV Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Diagnostic Imaging; Doxorubicin; Early Diagnosis; Epstein-Barr Virus Infections; Etoposide; Herpesviridae Infections; Herpesvirus 8, Human; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma, AIDS-Related; Lymphoma, Primary Effusion; Male; Methotrexate; Prednisone; Remission Induction; Rituximab; Vincristine; Viremia

2014
Autologous stem cell transplantation using MEAM regimen for relapsed AIDS-related lymphoma patients who received highly active anti-retroviral therapy: a report of three cases.
    Internal medicine (Tokyo, Japan), 2009, Volume: 48, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; HIV Infections; Humans; Lymphoma, AIDS-Related; Male; Melphalan; Nitrosourea Compounds; Recurrence; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous

2009
Dose-modified oral chemotherapy in the treatment of AIDS-related non-Hodgkin's lymphoma in East Africa.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Jul-20, Volume: 27, Issue:21

    Topics: Administration, Oral; Adolescent; Adult; Africa South of the Sahara; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; HIV Infections; HIV-1; Humans; Kenya; Lomustine; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Procarbazine; Treatment Outcome; Uganda; Virus Replication; Young Adult

2009
Chemotherapy as treatment for colo-colonic intussusception associated with acquired immune deficiency syndrome-related lymphoma.
    Surgery, 2011, Volume: 149, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Diseases; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Intussusception; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Male; Middle Aged; Prednisone; Tomography, X-Ray Computed; Treatment Outcome; Vincristine

2011
[Successful treatment with hyper-CVAD and highly active anti-retroviral therapy (HAART) for AIDS-related Burkitt lymphoma].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2010, Volume: 51, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Burkitt Lymphoma; Colonic Neoplasms; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Lymphoma, AIDS-Related; Male; Methotrexate; Prednisone; Treatment Outcome; Vincristine

2010
Clinical Features and Outcome in HIV-Associated Multicentric Castleman's Disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Jun-20, Volume: 29, Issue:18

    Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Castleman Disease; Comorbidity; Databases, Factual; Disease Progression; Disease-Free Survival; Drug Therapy, Combination; Etoposide; Female; Herpesviridae Infections; Herpesvirus 8, Human; HIV Infections; Humans; Incidence; Kaplan-Meier Estimate; Lymphoma, AIDS-Related; Male; Middle Aged; Proportional Hazards Models; Rituximab; Survival Analysis; Treatment Outcome; Young Adult

2011
Tumor melt: primary effusion lymphoma of the heart.
    The American journal of medicine, 2012, Volume: 125, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Doxorubicin; Echocardiography; Etoposide; Heart Neoplasms; Humans; Lymphoma, AIDS-Related; Lymphoma, Primary Effusion; Male; Middle Aged; Prednisone; Treatment Outcome; Vincristine

2012
Tailored chemotherapy for malignant lymphoma arising in the setting of posttransplant lymphoproliferative disorder after solid organ transplantation.
    Journal of pediatric hematology/oncology, 2002, Volume: 24, Issue:8

    Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Female; Heart Transplantation; Humans; Immunosuppression Therapy; Kidney Transplantation; Lung Neoplasms; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Male; Methotrexate; Postoperative Complications; Prednisone; Remission Induction; Stomach Neoplasms; Survival Analysis; Treatment Outcome; Vincristine

2002
HHV8-related non-Hodgkin's lymphoma of the spermatic cord in a patient with HIV-associated multicentric Castleman disease.
    American journal of hematology, 2003, Volume: 72, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Castleman Disease; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Genital Neoplasms, Male; Herpesviridae Infections; Herpesvirus 8, Human; Humans; Lymphoma, AIDS-Related; Male; Methotrexate; Middle Aged; Orchiectomy; Prednisone; Remission Induction; Sarcoma, Kaposi; Skin Neoplasms; Spermatic Cord; Splenectomy; Tumor Virus Infections; Vincristine

2003
Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology.
    Blood, 2003, Jun-15, Volume: 101, Issue:12

    Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cyclophosphamide; Doxorubicin; Drug Resistance, Viral; Etoposide; Female; HIV Reverse Transcriptase; Humans; Immunohistochemistry; Leukocyte Common Antigens; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Mutation; Prednisone; Prognosis; Reverse Transcriptase Inhibitors; Survival Rate; T-Lymphocytes; Treatment Outcome; Vincristine; Viral Load

2003
Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma.
    Cancer, 2003, Sep-15, Volume: 98, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, AIDS-Related; Male; Methotrexate; Middle Aged; Retrospective Studies

2003
Failure to eradicate AIDS-associated primary effusion lymphoma with high-dose chemotherapy and autologous stem cell reinfusion: case report and literature review.
    AIDS patient care and STDs, 2004, Volume: 18, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Carboplatin; CD4 Lymphocyte Count; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Immunophenotyping; Lymphoma, AIDS-Related; Male; Middle Aged; Pleural Effusion, Malignant; Prednisone; Salvage Therapy; Sarcoma, Kaposi; Skin Neoplasms; Stem Cell Transplantation; Transplantation, Autologous; Treatment Failure; Vincristine; Viral Load

2004
Potential antiretroviral drug interactions with cyclophosphamide, Doxorubicin, and Etoposide.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Feb-20, Volume: 23, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Cyclophosphamide; Doxorubicin; Drug Interactions; Etoposide; Humans; Lymphoma, AIDS-Related; Neutropenia; Protease Inhibitors

2005
HIV-associated lymphoma: promising new results, but with toxicity.
    Blood, 2005, Mar-01, Volume: 105, Issue:5

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug-Related Side Effects and Adverse Reactions; Etoposide; Humans; Infections; Lymphoma, AIDS-Related; Rituximab

2005
Highly active antiretroviral therapy and outcome of AIDS-related Burkitt's lymphoma or leukemia. Results of the PETHEMA-LAL3/97 study.
    Haematologica, 2005, Volume: 90, Issue:7

    Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Leucovorin; Leukemia; Lymphoma, AIDS-Related; Male; Methotrexate; Middle Aged; Prednisone; Treatment Outcome; Vincristine

2005
Current status of the treatment of HIV-associated lymphoma.
    Clinical advances in hematology & oncology : H&O, 2004, Volume: 2, Issue:1

    Topics: Anti-HIV Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Combined Modality Therapy; Cyclophosphamide; Disease Management; Doxorubicin; Drug Interactions; Etoposide; Hematopoietic Stem Cell Transplantation; HIV Infections; Hodgkin Disease; Humans; Lymphoma, AIDS-Related; Prednisone; Rituximab; Survival Analysis; Treatment Outcome; Vincristine

2004
Liposomal doxorubicin, cyclophosphamide, and etoposide and antiretroviral therapy for patients with AIDS-related lymphoma: a pilot study.
    The oncologist, 2006, Volume: 11, Issue:6

    Topics: Adult; Anti-Retroviral Agents; Antineoplastic Combined Chemotherapy Protocols; CD4 Lymphocyte Count; Cyclophosphamide; Doxorubicin; Drug Carriers; Etoposide; Female; Humans; Liposomes; Lymphoma, AIDS-Related; Male; Middle Aged; Pilot Projects; Survival Rate; Viral Load

2006
Treatment of AIDS-associated anaplastic large-cell lymphoma with dose-adjusted EPOCH chemotherapy.
    Journal of the National Medical Association, 2007, Volume: 99, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, AIDS-Related; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Vincristine

2007
A long-term durable remission with high-dose therapy and autologous stem cell transplant for stage IVB HIV-associated Hodgkins disease.
    AIDS (London, England), 2008, Feb-19, Volume: 22, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Cyclophosphamide; Cytarabine; Etoposide; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lomustine; Lymphoma, AIDS-Related; Male; Remission Induction; Transplantation, Autologous

2008
Administration of three cytokines instead of bone marrow transplantation in an HIV+ patient with high-grade lymphoma.
    European journal of haematology, 1994, Volume: 53, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cyclophosphamide; Cytarabine; Cytokines; Doxorubicin; Drug Therapy, Combination; Erythropoietin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lymphoma, AIDS-Related; Melphalan; Prednisolone; Vincristine

1994
Influence of molecular characteristics on clinical outcome in human immunodeficiency virus-associated non-Hodgkin's lymphoma: identification of a subgroup with favorable clinical outcome.
    Blood, 1995, Apr-01, Volume: 85, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blotting, Southern; CD4 Lymphocyte Count; Clone Cells; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; DNA, Neoplasm; DNA, Viral; Doxorubicin; Etoposide; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Genes, Immunoglobulin; Genes, myc; Granulocyte-Macrophage Colony-Stimulating Factor; Herpesvirus 4, Human; Humans; Immunoglobulin Variable Region; Immunologic Factors; Leucovorin; Life Tables; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Methotrexate; Polymerase Chain Reaction; Prednisone; Proportional Hazards Models; Radiotherapy, Adjuvant; Recombinant Proteins; RNA, Messenger; RNA, Neoplasm; Survival Analysis; Treatment Outcome; Vincristine

1995
Clinical trials referral resource. AIDS-related non-Hodgkin's lymphomas.
    Oncology (Williston Park, N.Y.), 1993, Volume: 7, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Erythropoietin; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Interleukin-3; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Prednisone; Vincristine; Zidovudine

1993
Novel oral combination chemotherapy in the treatment of intermediate-grade and high-grade AIDS-related non-Hodgkin's lymphoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993, Volume: 11, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Female; Flow Cytometry; Humans; Lomustine; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Procarbazine; Proportional Hazards Models; Quality of Life; Survival Analysis; Treatment Outcome

1993
Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:11

    Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; CD4 Lymphocyte Count; Cyclophosphamide; Didanosine; Doxorubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; HIV; HIV Core Protein p24; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pilot Projects; Recombinant Proteins; Survival Rate; Viremia

1996
Autologous bone marrow transplantation in relapsed HIV-related non-Hodgkin's lymphoma.
    Bone marrow transplantation, 1996, Volume: 18, Issue:6

    Topics: Adult; AIDS-Related Opportunistic Infections; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Burkitt Lymphoma; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Duodenal Neoplasms; Etoposide; Humans; Immunocompromised Host; Lymphoma, AIDS-Related; Lymphoma, Large B-Cell, Diffuse; Male; Methylprednisolone; Neoplasms, Second Primary; Pancytopenia; Remission Induction; Salvage Therapy; Thigh; Transplantation Conditioning; Vincristine

1996
Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy.
    Journal of the National Cancer Institute, 1997, Feb-19, Volume: 89, Issue:4

    Topics: Adult; AIDS-Related Opportunistic Infections; Analysis of Variance; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Cause of Death; CD4 Lymphocyte Count; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphocyte Subsets; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Risk; Survival Analysis

1997
Systemic chemotherapy alone for patients with non-acquired immunodeficiency syndrome-related central nervous system lymphoma: a pilot study of the BOMES protocol.
    Cancer, 1998, May-15, Volume: 82, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Disease Progression; Etoposide; Female; Humans; Lymphoma, AIDS-Related; Male; Methotrexate; Methylprednisolone Hemisuccinate; Middle Aged; Pilot Projects; Prospective Studies; Survival Rate; Treatment Outcome; Vincristine

1998
Patterns of central nervous system recurrence in patients with systemic human immunodeficiency virus-associated non-hodgkin lymphoma.
    Cancer, 1999, Nov-01, Volume: 86, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, AIDS-Related; Male; Meningitis; Middle Aged; Prospective Studies; Secondary Prevention

1999
Intensive chemotherapy (LNHIV-91 regimen) and G-CSF for HIV associated non-Hodgkin's lymphoma.
    Leukemia & lymphoma, 2000, Volume: 39, Issue:1-2

    Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD4 Lymphocyte Count; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Evaluation; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hospitalization; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Recurrence; Survival Rate; Treatment Outcome; Vindesine

2000
Topoisomerase II inhibitor induced leukemia in a patient with AIDS.
    AIDS (London, England), 2001, Feb-16, Volume: 15, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Homosexuality, Male; Humans; Idarubicin; Leukemia, Myeloid, Acute; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Neoplasm Metastasis; Neoplasms, Second Primary; Topoisomerase II Inhibitors

2001
HIV-associated non-Hodgkin lymphoma: incidence, presentation, and prognosis.
    JAMA, 2001, Apr-11, Volume: 285, Issue:14

    Topics: Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Biopsy, Needle; Cyclophosphamide; Doxorubicin; Etoposide; Flow Cytometry; HIV Infections; Humans; Immunohistochemistry; Immunophenotyping; Incidence; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Thrombolytic Therapy; Venous Thrombosis; Vincristine

2001
Induction of a TRAIL-mediated suicide program by interferon alpha in primary effusion lymphoma.
    Oncogene, 2001, Oct-25, Volume: 20, Issue:48

    Topics: Antimetabolites, Antineoplastic; Antiviral Agents; Apoptosis; Apoptosis Regulatory Proteins; Arabidopsis Proteins; bcl-X Protein; Biopolymers; Cysteine Endopeptidases; Drug Synergism; Enzyme Activation; Epstein-Barr Virus Infections; Etoposide; Fatty Acid Desaturases; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Herpesviridae Infections; Herpesvirus 4, Human; Herpesvirus 8, Human; HIV Infections; Humans; Immunocompromised Host; Immunologic Factors; Interferon-alpha; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Membrane Glycoproteins; Neoplasm Proteins; Proto-Oncogene Proteins c-bcl-2; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Thymidine; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Tumor Virus Infections; Zidovudine

2001
High-dose cytosine-arabinoside and cisplatin regimens as salvage therapy for refractory or relapsed AIDS-related non-Hodgkin's lymphoma.
    Journal of acquired immune deficiency syndromes (1999), 2001, Dec-15, Volume: 28, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cisplatin; Cytarabine; Dexamethasone; Drug Therapy, Combination; Etoposide; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Treatment Outcome

2001